wire - news in brief

Life Sciences - Aug 16
Life Sciences
Humans may have played a substantial role in the extinction of the European cave bear at the end of the last ice age. These findings of a study with the involvement of the University of Zurich suggest a drastic cave bear population decline starting around 40,000 years ago. Where in Europe did different populations of cave bears live and how they did they migrate during the Late Pleistocene? This is the topic that Verena Schünemann from the Institute of Evolutionary Medicine at the University of Zurich and a team of researchers investigated.
Health - Aug 15
Health

Numerous studies have shown that heat increases mortality rates. 1,2 In Switzerland, for example, the hot summer of 2015 caused around 800 additional deaths.

Computer Science - Aug 14
Computer Science

Scientists at EPFL have developed a tiny pump that could play a big role in the development of autonomous soft robots, lightweight exoskeletons and smart clothing.


Category



Results 1 - 50 of 325.
1 2 3 4 5 7 Next »


Life Sciences - Health - 17.08.2019
Function from structure: the double life of a DUB
Function from structure: the double life of a DUB
Deubiquitinases (DUBs) play a general role removing protein-degrading ubiquitins throughout the cell and are not typically known for specificity. Analyzing the two protein complexes BRISC and BRCA1-A, which have the same DUB core but play different roles in human biology, the Thomä group - in a collaboration with the Novartis Institutes for BioMedical Research (NIBR) - showed that DUBs can have diversified targeting and regulatory functions.

Pharmacology - Health - 16.08.2019
FDA approves Roche’s RozlytrekTM (entrectinib) for people with ROS1-positive, metastatic non-small cell lung cancer and NTRK gene fusion-positive solid tumours
First FDA-approved treatment designed to target both ROS1 and NTRK that also shows response in cancer that has spread to the brain Roche's first FDA-approved tumour-agnostic medicine Roche today announced that the US Food and Drug Administration (FDA) has approved Rozlytrek?

Health - Life Sciences - 15.08.2019
Major award for two Bernese medical projects
Major award for two Bernese medical projects
Prestigious grants from the USA go to two Bernese researchers: the biomedical scientists Marianna Kruithof-de Julio and Robert Rieben were the only researchers in Switzerland to receive a grant under

Environment - 15.08.2019
Pesticides Transformation products pollute groundwater
Pesticides Transformation products pollute groundwater
13 substances were detected for the first time in groundwater, 15 were found in concentrations above 100 ng/L. This is the threshold value for pesticides under the Water Protection Ordinance. The researchers are particularly targeting metabolites of chlorothalonil, a product used against fungal attack in cereal, vegetable, wine and ornamental plant cultivation.

Electroengineering - 09.08.2019

Computer Science / Telecom - Microtechnics - 08.08.2019
Self healing robots that
Self healing robots that "feel pain"
Over the next three years, researchers from the Vrije Universiteit Brussel, University of Cambridge, École Supérieure de Physique et de Chimie Industrielles de la ville de Paris (ESPCI-Paris) and Empa will be working together with the Dutch Polymer manufacturer SupraPolix on the next generation of robots: (soft) robots that 'feel pain' and heal themselves.

Pharmacology - Life Sciences - 07.08.2019
Novartis stands behind Zolgensma (onasemnogene abeparvovec-xioi) for the treatment of children less than 2 years of age with spinal muscular atrophy
Basel, August 6, 2019 - Today the FDA released a statement addressing data integrity issues with the Biologics License Application (BLA) for Zolgensma (onasemnogene abeparvovec-xioi). First and foremost, we are fully confident in the safety, quality and efficacy of Zolgensma. The FDA supports the continued marketing and use of Zolgensma for patients with spinal muscular atrophy (SMA) less than 2 years of age.

Administration - Career - 06.08.2019
Doctorate - what's next?
Doctorate - what’s next?
The supervision of doctoral students has long been the subject of intense debate both within and beyond the walls of our university.

Pharmacology - Health - 05.08.2019
Roche’s Tecentriq plus platinum-based chemotherapy reduced the risk of disease worsening or death in people with previously untreated advanced bladder cancer
IMvigor130 is the first positive Phase III study of a cancer immunotherapy combination in previously untreated advanced bladder cancer Data will be shared with health authorities globally, including

Environment - Innovation / Technology - 05.08.2019

Environment - 31.07.2019

Music - Computer Science / Telecom - 30.07.2019
A new way to experience traditional music of Afghanistan
A new way to experience traditional music of Afghanistan
(Summer Series): Mathieu Clavel, a master's student in the College of Humanities (CDH) Digital Humanities Institute, is bringing musical heritage from Afghanistan to life using tools from data science and virtual reality.

Health - Psychology - 30.07.2019

Environment - Life Sciences - 30.07.2019
Buzzing with life
Buzzing with life
The ETH Zurich Zentrum and Hönggerberg campuses are not just the study and office spaces of the 30,000 members of ETH: they are also home to a variety of animals and plants.

Pharmacology - Health - 26.07.2019
Novartis receives positive CHMP opinion for Lucentis treatment
Lucentis (ranibizumab), if approved in the EU for this indication, will be the first and only pharmacological therapy for ROP in these vulnerable infants Positive opinion is based on the landmark Pha

Pharmacology - Health - 26.07.2019
CHMP recommends EU approval of Roche’s Tecentriq in combination with chemotherapy
Decision based on results from first Phase III study to show a cancer immunotherapy-based combination significantly improved overall survival (OS) and progression-free survival (PFS) in over 20 years

Earth Sciences - 26.07.2019

Agronomy / Food Science - 25.07.2019

Environment - 24.07.2019
Partnering up for sustainable buildings
Partnering up for sustainable buildings
Empa and the Korean Institute of Civil Engineering and Building Technology (KICT) are committed to working together for a sustainable and networked society.

Mechanical Engineering - 22.07.2019
Swissloop comes second in the Hyperloop competition
Swissloop comes second in the Hyperloop competition
At yesterday's Hyperloop Competition in Los Angeles, the Swissloop pod achieved a top speed of 252 km/h.

Innovation / Technology - 22.07.2019
EPFLoop races to third place in Los Angeles
EPFLoop races to third place in Los Angeles
Using similar propulsion technology, the Hyperloop pods developed by EPFL and ETH Zurich turned in a solid performance in Los Angeles: EPFLoop topped out at 238 km/h in the airless tube set up by SpaceX, while Swissloop peaked at 259km/h.

Business / Economics - Event - 22.07.2019

Innovation / Technology - 22.07.2019

Life Sciences - Health - 21.07.2019
150 years of DNA
150 years of DNA
DNA has become the icon of modern bioscience but few people realize that it was Friedrich Miescher, who - almost a century before Watson and Crick - laid the chemical groundwork for the molecular breakthroughs that followed. Today, 150 years after Miescher's first ‘discovery' of DNA, we want to highlight his remarkable work.

Health - 20.07.2019
EPFLoop ready to roll in Los Angeles
EPFLoop ready to roll in Los Angeles
The finals of the SpaceX Hyperloop Pod Competition will take place this Sunday. The crowning race will play out in an airless tube, and EPFL's student team is among the top three contenders.

Innovation / Technology - 18.07.2019
EPFL startup develops innovative method for recycling PET
DePoly, a startup based at EPFL's Valais-Wallis campus, has developed a chemical-based method for recycling PET containers.

Materials Science - 17.07.2019

Life Sciences - Innovation / Technology - 16.07.2019
Evaluating the risks posed by synthetic biology
Last week, nearly 70 experts from around the world gathered at EPFL for a workshop on potential threats arising from synthetic biology.

Environment - 16.07.2019

Health - Pharmacology - 16.07.2019
FDA accepts file and accelerates review of Novartis sickle cell disease medicine crizanlizumab (SEG101)
FDA grants crizanlizumab Priority Review based on Phase II data showing prevention of vaso-occlusive crises (VOCs) in patients with sickle cell disease, shortening FDA review to six months from stand

Environment - 10.07.2019
Shared e-cargo bikes: boom and barriers in Basel
Shared e-cargo bikes: boom and barriers in Basel
Sustainable means of mobility are becoming ever more popular. In Switzerland, around 15,000 people have registered with the online platform carvelo2go, which hires out electric cargo bikes.

Pharmacology - Health - 09.07.2019
Roche presents a broad range of data for Hemlibra demonstrating continued benefits for people with haemophilia A at the ISTH 2019 Congress
New analyses from phase III HAVEN studies support Hemlibra's sustained efficacy, safety and quality of life benefit in people with haemophilia A, with and without factor VIII inhibitors First data of

Computer Science / Telecom - Social Sciences - 08.07.2019
The math of detecting communities
The math of detecting communities
Emmanuel Abbé is the new Chair of Mathematical Data Science at EPFL. His work answers fundamental questions in machine learning and information theory, and in particular on community detection. Sociologists study the patterns of everyday social interactions and relationships by structuring society in a network.
1 2 3 4 5 7 Next »